Zobrazeno 1 - 10
of 151
pro vyhledávání: '"Boucher CAB"'
Autor:
Vandekerckhove, LPR, Wensing, AMJ, Kaiser, R, Brun-Vézinet, F, Clotet, B, De Luca, A, Dressler, S, Garcia, F, Geretti, AM, Klimkait, T, Korn, K, Masquelier, B, Perno, CF, Schapiro, JM, Soriano, V, Sönnerborg, A, Vandamme, A-M, Verhofstede, C, Walter, H, Zazzi, M, Boucher, CAB
Publikováno v:
In The Lancet Infectious Diseases 2011 11(5):394-407
Autor:
Casadella, M, van Ham, PM, Noguera-Julian, M, van Kessel, A, Pou, C, Hofstra, LM, Santos, JR, Garcia, F, Struck, D, Alexiev, I, Kran, AMB, Hoepelman, AI, Kostrikis, LG, Somogyi, S, Liitsola, K, Linka, M, Nielsen, C, Otelea, D, Paraskevis, D, Poljak, M, Puchhammer-Stockl, E, Stanekova, D, Stanojevic, M, Van Laethem, K, Lepej, SZ, Clotet, B, Boucher, CAB, Paredes, R, Wensing, AMJ, Domingo P., SPREAD Programme
Publikováno v:
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Objectives: The objective of this study was to define the natural genotypic variation of the HIV-1 integrase gene across Europe for epidemiological surveillance of integrase strand-transfer inhibitor (InSTI) resistance. Methods: This was a multicentr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::132f2a171f7351e5cfd4d5c2e2a6f7a4
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=8298
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=8298
Autor:
Wijting, IEA, Rutsaert, SL, Rokx, C, Burger, DM, Verbon, A, Kampen, JJA, Boucher, CAB, Rijnders, BJA, Vandekerckhove, L
Publikováno v:
HIV Medicine; Jan2019, Vol. 20 Issue 1, p63-68, 6p
Autor:
Swartz, JE, de Vries, A, Ammerlaan, H, Begovac, Josip, Bierman, WF, Boucher, CAB, van der Ende, ME, Grossman, Z, Kaiser, R, Levi, I, Mudrikova, T, Paredes, R, Perez-Bercoff, D, Pronk, M, Richter, C, Schmit, JC, Vandekerckhove, L, Vercauteren, J, Zazzi, M, Židovec Lepej, Snježana, DeLuca, A, Wensing, AMJ, on behalf of the European Society for Antiviral Resistance- ESAR
Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in clinical practice in Europe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::fcc59e30202c4a8e5a5252a8c61d2782
https://www.bib.irb.hr/669402
https://www.bib.irb.hr/669402
Autor:
DANNER, SA, CARR, A, LEONARD, JM, LEHMAN, LM, GUDIOL, F, GONZALES, J, RAVENTOS, A, RUBIO, R, BOUZA, E, PINTADO, Olga, AGUADO, AG, DELOMAS, JG, DELGADO, R, BORLEFFS, JCC, HSU, A, VALDES, JM, BOUCHER, CAB, COOPER, DA, GIMENO, C, CLOTET, B, TOR, J, FERRER, E, MARTINEZ, PL, MORENO, S, ZANCADA, G, ALCAMI, J, NORIEGA, AR, PULIDO, F, GLASSMAN, HN
Publikováno v:
Recercat. Dipósit de la Recerca de Catalunya
instname
New England Journal of Medicine, 333(23), 1528-1533. MASSACHUSETTS MEDICAL SOC
Dipòsit Digital de la UB
Universidad de Barcelona
Danner, S A, Carr, A, Leonard, J M, Lehman, L M, Gudiol, F, Gonzales, J, Raventos, A, Rubio, R, Bouza, E, Pintado, V, Aguado, A G, Garcia de Lomas, J, Delgado, R, Borleffs, J C C, Hsu, A, Valdes, J M, Boucher, C A B & Cooper, D A 1995, ' A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of hiv-1 protease ', New England Journal of Medicine, vol. 333, no. 23, pp. 1528-1534 . https://doi.org/10.1056/NEJM199512073332303
New England Journal of Medicine, 333(23), 1528-1534. Massachussetts Medical Society
instname
New England Journal of Medicine, 333(23), 1528-1533. MASSACHUSETTS MEDICAL SOC
Dipòsit Digital de la UB
Universidad de Barcelona
Danner, S A, Carr, A, Leonard, J M, Lehman, L M, Gudiol, F, Gonzales, J, Raventos, A, Rubio, R, Bouza, E, Pintado, V, Aguado, A G, Garcia de Lomas, J, Delgado, R, Borleffs, J C C, Hsu, A, Valdes, J M, Boucher, C A B & Cooper, D A 1995, ' A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of hiv-1 protease ', New England Journal of Medicine, vol. 333, no. 23, pp. 1528-1534 . https://doi.org/10.1056/NEJM199512073332303
New England Journal of Medicine, 333(23), 1528-1534. Massachussetts Medical Society
Background. Reverse-transcriptase inhibitors have only moderate clinical efficacy against the human immunodeficiency virus type 1 (HIV-1). Ritonavir is an inhibitor of HIV-1 pretease with potent in vitro anti-HIV properties and good oral bioavailabil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60c0eb9dac655acaa35a14698702748c
https://doi.org/10.1056/NEJM199512073332303
https://doi.org/10.1056/NEJM199512073332303
Autor:
Vandekerchove, L, Wensing, AM, Kaiser, R, Brun-Vezinet, F, Clotet, B, De Luca, A, Dressler, S, Garcia, F, Geretti, AM, Klimkait, T, Korn, K, Masquelier, B, Perno, CF, Shapiro, JM, Soriano, V, Sonnerborg, A, Vandamme, AM, Verhofstede, C, Walter, H, Zazzi, M, Boucher, CAB, Židovec Lepej, Snježana
Introduction: Testing for HIV tropism is recommended before prescribing a chemokine receptor blocker. To date, in most European countries HIV tropism is determined using a phenotypic test. Recently, new data have emerged supporting the use of a genot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::486e938cad3361d918ff63584f2134c0
https://www.bib.irb.hr/669415
https://www.bib.irb.hr/669415
Background: The genetic barrier, defined as the number of mutations required to overcome drug-selective pressure, is an important factor for the development of HIV drug resistance. Because of high variability between subtypes, particular HIV-1 subtyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::a247a6d8859de721a5297289eafcc1f9
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3098985
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3098985
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.